» Articles » PMID: 27620842

MiR-137: an Important Player in Neural Development and Neoplastic Transformation

Overview
Journal Mol Psychiatry
Date 2016 Sep 14
PMID 27620842
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) represent an important class of small regulatory RNAs that control gene expression posttranscriptionally by targeting mRNAs for degradation or translation inhibition. Early studies have revealed a complex role for miRNAs in major biological processes such as development, differentiation, growth and metabolism. MiR-137 in particular, has been of great interest due to its critical role in brain function and putative involvement in the etiology of both neuropsychiatric disorders and cancer. Several lines of evidence suggest that development, differentiation and maturation of the nervous system is strongly linked to the expression of miR-137 and its regulation of a large number of downstream target genes in various pathways. Dysregulation of this molecule has also been implicated in major mental illnesses through its position in a variant allele highly associated with schizophrenia in the largest mega genome-wide association studies. Interestingly, miR-137 has also been shown to act as a tumor suppressor, with numerous studies finding reduced expression in neoplasia including brain tumor. Restoration of miR-137 expression has also been shown to inhibit cell proliferation, migration and metastasis, and induce cell cycle arrest, differentiation and apoptosis. These properties of miR-137 propose its potential for prognosis, diagnosis and as a therapeutic target for treatment of several human neurological and neoplastic disorders. In this review, we provide details on the discovery, targets, function, regulation and disease involvement of miR-137 with a broad look at recent discovery in this area.

Citing Articles

Recent Advances in the miRNA-Mediated Regulation of Neuronal Differentiation and Death.

Patranabis S Neuromolecular Med. 2024; 26(1):52.

PMID: 39648193 DOI: 10.1007/s12017-024-08820-2.


miR-137: a potential therapeutic target for lung cancer.

Liu S, Ruan Y, Chen X, He B, Chen Q Front Cell Dev Biol. 2024; 12:1427724.

PMID: 39247624 PMC: 11377224. DOI: 10.3389/fcell.2024.1427724.


The role of YAP/TAZ mechanosignaling in trabecular meshwork and Schlemm's canal cell dysfunction.

Ghosh R, Herberg S Vision Res. 2024; 224:108477.

PMID: 39208753 PMC: 11470804. DOI: 10.1016/j.visres.2024.108477.


miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses.

Toropko M, Chuvpilo S, Karabelsky A Pharmaceutics. 2024; 16(8).

PMID: 39204331 PMC: 11360794. DOI: 10.3390/pharmaceutics16080986.


MicroRNAs as potential diagnostic biomarkers for bipolar disorder.

Martinez B, Peplow P Neural Regen Res. 2024; 20(6):1681-1695.

PMID: 39104098 PMC: 11688563. DOI: 10.4103/NRR.NRR-D-23-01588.


References
1.
Liu M, Lang N, Qiu M, Xu F, Li Q, Tang Q . miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int J Cancer. 2010; 128(6):1269-79. DOI: 10.1002/ijc.25452. View

2.
Johnson R, Zuccato C, Belyaev N, Guest D, Cattaneo E, Buckley N . A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis. 2007; 29(3):438-45. DOI: 10.1016/j.nbd.2007.11.001. View

3.
Dacic S, Kelly L, Shuai Y, Nikiforova M . miRNA expression profiling of lung adenocarcinomas: correlation with mutational status. Mod Pathol. 2010; 23(12):1577-82. DOI: 10.1038/modpathol.2010.152. View

4.
Leonardi G, Candido S, Carbone M, Colaianni V, Garozzo S, Cina D . microRNAs and thyroid cancer: biological and clinical significance (Review). Int J Mol Med. 2012; 30(5):991-9. DOI: 10.3892/ijmm.2012.1089. View

5.
Kim A, Parker E, Williamson V, McMichael G, Fanous A, Vladimirov V . Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. Schizophr Res. 2012; 141(1):60-64. PMC: 4104606. DOI: 10.1016/j.schres.2012.06.038. View